GUEST SERIES: Reliable Gene testing for Cancer & CVD risk w Dahlia Attia-King CEO of Panacea

In this episode of Func Med Nation, Dr. Steven Noseworthy, DC, interviews Dahlia, Founder and CEO of Panacea. With a BS in Biology and Chemistry from the University of Miami and extensive experience in genetic laboratories and healthcare technology, Dahlia shares her mission to make preventative genetic testing accessible to more patients and practitioners. Dahlia discusses the major barriers preventing widespread adoption of valuable genetic testing — including lack of insurance coverage and physician hesitancy — and how Panacea is working to overcome these obstacles. The conversation explores practical ways functional medicine practitioners can integrate genetic insights into clinical care, improve preventative strategies, and navigate the evolving landscape of precision health. Listeners will gain valuable insights into the current state of genetic testing, strategies to increase testing adoption, and how personalized genomics can enhance patient outcomes in functional medicine practice. Key Topics: • Barriers to preventive genetic testing in clinical practice • Building solutions in healthcare technology for precision and preventative medicine • Practical applications of genetic testing in functional medicine • Dahlia’s journey from laboratory science to founding Panacea This episode offers actionable perspectives for clinicians seeking to leverage genetic data to deliver more proactive, personalized care. Tune in for an enlightening discussion on bridging the gap between genetic science and accessible clinical care. Available now on your favorite podcast platform. LINKS • Panacea on the Web (https://seekpanacea.com/) • Dr. Noseworthy on the Web. (https://www.drnoseworthy.com/)